Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash Flows from Operating Activities
Net loss	$ (12,813,325)	$ (23,812,077)
Adjustment to reconcile net loss to net cash used in operating activities:
Changes in fair value of warrant liabilities	(7,496,500)	(5,322,500)
Changes in fair value of earn-out liabilities	(460,000)	(340,000)
Share-based compensation	3,552,984	11,058,185
Amortization of step-up in loans held for investment	169,607	269,829
Provision for credit losses on loans held for investment and lease merchandise	1,152,420	154,202
Origination of loans and leases for resale	(14,825,985)	(10,124,894)
Proceeds from sale of loans and leases for resale	16,384,107	11,247,135
Gain on sale of loans and leases	(1,558,122)	(1,122,241)
Depreciation and amortization	2,893,612	1,227,471
Non-cash operating lease expense	114,410	208,564
Changes in operating assets and liabilities:
Accounts receivable	(175,697)	(135,715)
Lease receivable	(152,463)	0
Interest receivable	95,625	(358,270)
Inventory	122,135	161,473
Prepaid expenses and other current assets	223,867	1,571,121
Deposits	(21,705)	13,929
Accounts payable	(627,932)	(1,335,335)
Accrued expenses	249,917	(110,806)
Deferred revenue	2,000,177	16,636
Operating lease liabilities	(112,688)	(206,258)
Net cash used in operating activities	(11,285,556)	(16,939,551)
Cash flows from Investing Activities
Additions to lease merchandise, net of disposals	(2,194,358)	0
Software development costs	(1,554,442)	(1,777,479)
Principal paydowns on loans held for investment	8,911,312	5,265,396
Disbursements for loans held for investment	(9,406,157)	(3,576,860)
Purchase of licenses	(455,000)	0
Acquisition of businesses, net of cash acquired	0	141,215
Net cash (used in) provided by investing activities	(4,698,645)	52,272
Cash flows from Financing Activities
Proceeds from convertible note payable, related party (Note 9)	0	10,000,000
Proceeds from revolving line of credit	4,761,935	0
Repayments on revolving line of credit	(4,532,580)	(1,808,833)
Proceeds from the issuance of common stock for at-the-market offering	361,528	0
Cash paid for stock issuance costs	(312,059)	0
Net cash provided by financing activities	278,824	8,191,167
Net decrease in cash, cash equivalents and restricted cash	(15,705,377)	(8,696,112)
Cash, cash equivalents and restricted cash, beginning of period	36,589,607	16,446,030
Cash, cash equivalents and restricted cash, end of the period	20,884,230	7,749,918
Cash and cash equivalents	20,577,116	7,613,430
Restricted cash	307,114	136,488
Total cash, cash equivalents and restricted cash, end of the period	20,884,230	7,749,918
Supplemental Non-Cash Investing and Financing Activity
Issuance of common shares in connection with the asset acquisition	4,500,000	0
Earnout liability generated by asset acquisition	550,000	0
Operating lease right-of-use asset obtained in exchange for operating lease liability	652,410	0
Accrued variable compensation settled with RSU grants	597,397	411,878
Shares issued in connection with Credova Merger	0	14,137,606
Note Exchange in connection with Credova Merger	$ 0	$ 8,449,500